Evidence map›Paper›PMID 34238283›Full record

ArticleRespiratory research2021

Validation and minimum important difference of the UCSD Shortness of Breath Questionnaire in fibrotic interstitial lung disease.

Tao Chen, Amy Po Yu Tsai, Seo Am Hur, Alyson W Wong, Mohsen Sadatsafavi, Jolene H Fisher, Kerri A Johannson, Deborah Assayag, Julie Morisset, Shane Shapera and 11 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Respiratory research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 10 institutions in 2 countries.

Tao ChenDepartment of Medicine, University of British Columbia, Vancouver, BC, Canada.
Amy Po Yu TsaiDepartment of Medicine, University of British Columbia, Vancouver, BC, Canada.
Seo Am HurDepartment of Medicine, University of British Columbia, Vancouver, BC, Canada.
Alyson W WongDepartment of Medicine, University of British Columbia, Vancouver, BC, Canada.
Mohsen SadatsafaviRespiratory Evaluation Sciences Program, Collaboration for Outcomes Research and Evaluation, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada.
Jolene H FisherDepartment of Medicine, University of Toronto, Toronto, ON, Canada.
Kerri A JohannsonDepartment of Medicine, University of Calgary, Calgary, AB, Canada.
Deborah AssayagDepartment of Medicine, McGill University, Montreal, QC, Canada.
Julie MorissetDepartment of Medicine, University of Calgary, Calgary, AB, Canada.
Shane ShaperaDepartment of Medicine, University of Toronto, Toronto, ON, Canada.
Nasreen KhalilDepartment of Medicine, University of British Columbia, Vancouver, BC, Canada.
Charlene D FellDepartment of Medicine, University of Calgary, Calgary, AB, Canada.
Helene ManganasDépartement de Médecine, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada.
Gerard CoxDepartment of Medicine, Firestone Institute for Respiratory Health, McMaster University, Hamilton, ON, Canada.
Teresa ToChild Health Evaluative Sciences, The Hospital for Sick Children, Toronto, ON, Canada.
Andrea S GershonDepartment of Medicine, University of Toronto, Toronto, ON, Canada.
Nathan HamblyDepartment of Medicine, Firestone Institute for Respiratory Health, McMaster University, Hamilton, ON, Canada.
Andrew J HalaykoDepartments of Internal Medicine and Physiology and Pathophysiology, University of Manitoba, Winnipeg, MB, Canada.
Pearce G WilcoxDepartment of Medicine, University of British Columbia, Vancouver, BC, Canada.
Martin KolbDepartment of Medicine, Firestone Institute for Respiratory Health, McMaster University, Hamilton, ON, Canada.
Christopher J RyersonDepartment of Medicine, University of British Columbia, Vancouver, BC, Canada. chris.ryerson@hli.ubc.ca.ORCID http://orcid.org/0000-0003-1049-393X
University of British Columbia · CAMcMaster University · CAUniversity of Calgary · CAUniversity of Toronto · CACentre Hospitalier de l’Université de Montréal · CAMcGill University · CASunnybrook Health Science Centre · CATongji University · CNUniversity of British Columbia Hospital · CAUniversity of Manitoba · CA

Funding

Boehringer Ingelheim 20R23666China Scholarship Council 201906260235
6 · The paper itself

Abstract

rationaleThe University of California, San Diego Shortness of Breath Questionnaire (UCSDSOBQ) is a frequently used domain-specific dyspnea questionnaire; however, there is little information available regarding its use and minimum important difference (MID) in fibrotic interstitial lung disease (ILD). We aimed to describe the key performance characteristics of the UCSDSOBQ in this population.

methodsUCSDSOBQ scores and selected anchors were measured in 1933 patients from the prospective multi-center Canadian Registry for Pulmonary Fibrosis. Anchors included the St. George's Respiratory Questionnaire (SGRQ), European Quality of Life 5 Dimensions 5 Levels questionnaire (EQ-5D-5L) and EQ visual analogue scale (EQ-VAS), percent-predicted forced vital capacity (FVC%), diffusing capacity of the lung for carbon monoxide (DLCO%), and 6-min walk distance (6MWD). Concurrent validity, internal consistency, ceiling and floor effects, and responsiveness were assessed, followed by estimation of the MID by anchor-based (linear regression) and distribution-based methods (standard error of measurement).

resultsThe UCSDSOBQ had a high level of internal consistency (Cronbach's alpha = 0.97), no obvious floor or ceiling effect, strong correlations with SGRQ, EQ-5D-5L, and EQ-VAS (|r| > 0.5), and moderate correlations with FVC%, DLCO%, and 6MWD (0.3 < |r| < 0.5). The MID estimate for UCSDSOBQ was 5 points (1-8) for the anchor-based method, and 4.5 points for the distribution-based method.

conclusionThis study demonstrates the validity of UCSDSOBQ in a large and heterogeneous population of patients with fibrotic ILD, and provides a robust MID estimate of 5-8 points.

Indexed as

AgedCanadaCohort StudiesDyspneaFemaleHumansLung Diseases, InterstitialMaleMiddle AgedProspective StudiesPulmonary FibrosisRegistriesReproducibility of ResultsSurveys and QuestionnairesVital CapacityDyspneaInterstitial lung diseaseMinimum clinically important differencePulmonary fibrosis

Identifiers

PMID34238283
PMCPMC8265065
OpenAlexW3163074353

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.